The Body: The Complete HIV/AIDS Resource
Follow Us Follow Us on Facebook Follow Us on Twitter Download Our App 
Professionals >> Visit The Body PROThe Body en Espanol
Ask the Experts About

HIV Drug ResistanceHIV Drug Resistance
Rollover images to visit our other forums!
  • Email Email
  • Glossary Glossary

Benefits from resistance testing?
Aug 23, 1999

I've been on HAART therapy for approx. 2 years most recently adding d4t a few months ago. while my viral load was never over 50K, it has remained at or near undetectable levels since starting viracept, 3tc and sustiva. my t-cells however, seem to be gradually dropping from approx 200+ one year ago to 150 now. i must add i've been on the 3tc for quite some time.

my question concerns whether there may be a benefit to doing resistance testing to identify the possibility that one or more of the drugs is simply no longer effective and the benefits to viral load are, in fact, caused by only some of the drugs i'm currently taking.

thanks, mark

Response from Dr. Holodniy

You may in fact be correct about the implied benefit of some,but not all of the drugs in your regimen. If your viral load is undetectable, then resistance testing will probably not be able to be used. The test usually requires a viral load of 500-1000/ml to have enough virus for the test to be performed. MH

A question about resistance
Drug Holiday-Wild Type Virus

  • Email Email
  • Glossary Glossary



This forum is designed for educational purposes only, and experts are not rendering medical, mental health, legal or other professional advice or services. If you have or suspect you may have a medical, mental health, legal or other problem that requires advice, consult your own caregiver, attorney or other qualified professional.

Experts appearing on this page are independent and are solely responsible for editing and fact-checking their material. Neither nor any advertiser is the publisher or speaker of posted visitors' questions or the experts' material.

Review our complete terms of use and copyright notice.

Powered by ExpertViewpoint